Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Academic Article uri icon

Overview

MeSH Major

  • Adenosine Triphosphate
  • Myocardial Ischemia
  • Phosphocreatine

abstract

  • Among women without CAD, abnormal MRS consistent with myocardial ischemia predicted cardiovascular outcome, notably higher rates of anginal hospitalization, repeat catheterization, and greater treatment costs. Further evaluation into the underlying pathophysiology and possible treatment options for women with evidence of myocardial ischemia but without CAD is indicated.

publication date

  • June 22, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/01.CIR.0000130642.79868.B2

PubMed ID

  • 15197152

Additional Document Info

start page

  • 2993

end page

  • 9

volume

  • 109

number

  • 24